Borrelia Burgdorferi, B-31 Strain,Borrelia Burgdorferi, Ips Strain
59 adverse event reports submitted to the FDA
Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
59
Total Reports
1
Deaths Reported
170.0%
Death Rate
Active Ingredients
Borrelia Burgdorferi, B-31 Strain,Borrelia Burgdorferi, Ips Strain
Administration Routes
SubcutaneousUnknownParenteral
Species Affected
Dog 58
Unknown 1
Most Affected Breeds
Retriever - Labrador 11
Shepherd Dog - Australian 5
Retriever - Golden 5
Crossbred Canine/dog 4
Shepherd Dog - German 4
Spaniel - Cocker American 2
Terrier (unspecified) 2
Great Pyrenees 2
Siberian Husky 2
Boxer (German Boxer) 2
Most Reported Reactions
Lack of efficacy (bacteria) - Borrelia 43
Lethargy (see also Central nervous system depression in Neurological) 8
Other abnormal test result NOS 8
Lack of efficacy (bacteria) - Anaplasma 8
Diarrhoea 6
Weight loss 6
Vomiting 6
Low platelet count 4
Lameness 4
Elevated haematocrit 4
Elevated blood urea nitrogen (BUN) 4
Increased percentage reticulocytes 3
Outcome Breakdown
Outcome Unknown
47 (81.0%)
Ongoing
6 (10.3%)
Recovered/Normal
4 (6.9%)
Euthanized
1 (1.7%)
Source: FDA Center for Veterinary Medicine — Adverse Event Reports. Data reflects voluntary submissions and may not represent actual incidence rates.